Logo

Is precision treatment of KRAS mutant NSCLC advancing? What is the best strategy?

Prof. Dr. I. Demedts, AZ Delta, Roeselare
Dr. A. Sibille, CHU de Liège
Dr. L. Pirard, CHU UCL Namur, Godinne